96-WELL FORMAT-BASED MICROFLUIDIC PLATFORM FOR HIGH-THROUGHPUT DRUG SCREENING

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

In this study, a simple and robust microfluidic platform is presented, which can interconnect and culture multiple microtissues (MTs) as 96-well format-based platform. Human colon cancer (HCT116) MTs were cultured over 4 days and exposed to various concentrations of endoxifen. Drug resistance was observed when HCT116 MTs were cultured under perfusion conditions. It addresses the feasibility of our microfluidic platform for more complex and comprehensive pharmacokinetic study in an in vivo-like in vitro physiological environment.

Original languageEnglish
Title of host publicationMicroTAS 2021 - 25th International Conference on Miniaturized Systems for Chemistry and Life Sciences
PublisherChemical and Biological Microsystems Society
Pages1689-1690
Number of pages2
ISBN (Electronic)9781733419031
StatePublished - 2021
Event25th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2021 - Palm Springs, Virtual, United States
Duration: 10 Oct 202114 Oct 2021

Publication series

NameMicroTAS 2021 - 25th International Conference on Miniaturized Systems for Chemistry and Life Sciences

Conference

Conference25th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2021
Country/TerritoryUnited States
CityPalm Springs, Virtual
Period10/10/2114/10/21

Bibliographical note

Publisher Copyright:
© 2021 MicroTAS 2021 - 25th International Conference on Miniaturized Systems for Chemistry and Life Sciences. All rights reserved.

Keywords

  • 3D cell culture
  • High-throughput drug screening
  • Microfluidics
  • Microtissue

Fingerprint

Dive into the research topics of '96-WELL FORMAT-BASED MICROFLUIDIC PLATFORM FOR HIGH-THROUGHPUT DRUG SCREENING'. Together they form a unique fingerprint.

Cite this